But there must have been some issue with the extended release version IMHO. The FDA often issues approvable when it means no approval, run more tests. Why issue a not approvable if it is simply a volume thing?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.